Showing results (91-100 of 542) with videos related to
Sort By:
Pageof 55
BMJ Case Reports|August 14, 2024
Posterior reversible encephalopathy syndrome (PRES) in classic Hodgkin's lymphoma, complicated by anthracycline-induced cardiomyopathyRose Hall, Bambang Atmaja, Bhupinder Sharma, et al.Critical Reviews in Oncology/Hematology|April 30, 2015
Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targetsFrancesco Sclafani, Ridhima Iyer, David Cunningham, et al.Lancet (London, England)|June 27, 2017
Oesophageal cancerJesper Lagergren, Elizabeth Smyth, David Cunningham, et al.Education for Primary Care : an Official Publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors|January 24, 2022
GP trainee prescribing assessment - a qualitative evaluation of the involvement of pharmacistsKatherine Brown, David Cunningham, Rachael Allan, et al.Cancers|February 15, 2022
Optimising Multimodality Treatment of Resectable Oesophago-Gastric AdenocarcinomaAli Abdulnabi Suwaidan, Anderley Gordon, Elizabeth Cartwright, et al.Pancreas|March 7, 2013
Gemcitabine plus capecitabine in unselected patients with advanced pancreatic cancerRichard A Hubner, Fiona Worsnop, David Cunningham, et al.The Oncologist|October 23, 2012
Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?Sarah Barton, Eliza A Hawkes, Andrew Wotherspoon, et al.The Oncologist|June 3, 2011
Targeting angiogenesis in esophagogastric adenocarcinomaAlicia F C Okines, Andrew R Reynolds, David CunninghamTherapeutic Advances in Medical Oncology|December 22, 2018
Immunotherapy and pancreatic cancer: unique challenges and potential opportunitiesKate Young, Daniel J Hughes, David Cunningham, et al.Journal of Geriatric Oncology|September 28, 2013
Factors affecting survival in patients aged 60 and over with diffuse large B cell lymphoma failing first-line therapyLisa Lowry, Paul Smith, David Cunningham, et al.Pageof 55